Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  1974

• Venue

  European Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000114602PMID 4413508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The free amino acids in human cerebrospinal fluid

  1972cited by this paper
• Cerebrospinal fluid amino acids in extrapyramidal disorders before and after L-DOPA treatment

  1971cited by this paper
• Plasma-aminoacid levels in Huntington's chorea.

  1969cited by this paper
• [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

  1969cited by this paper
• A versatile lithium buffer elution system for single column automatic amino acid chromatography.

  1968cited by this paper
• HOMOCARNOSINE IN HUMAN CEREBROSPINAL FLUID: AN AGE‐DEPENDENT PHENOMENON 1

  1968cited by this paper
• THE FREE AMINO ACIDS OF HUMAN SPINAL FLUID DETERMINED BY ION EXCHANGE CHROMATOGRAPHY

  1966cited by this paper

• Unveiling Parkinson’s disease through biomarker research: current insights and future prospects

  2024cites this paper
• Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases

  2022cites this paper
• Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s disease: review and meta‐analysis

  2020cites this paper
• Cerebrospinal fluid biomarkers of Parkinson's disease: an update

  2020cites this paper
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• An Update on CSF Biomarkers of Parkinson’s Disease

  2013cites this paper
• Glutamatergic Dysfunction in OCD

  2005cites this paper
• Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: Correlation with clinical profiles and neurochemistry

  2003cites this paper
• Amino Acids and Biogenic Amines in Cerebrospinal Fluid of Patients with Parkinson's Disease

  2003cites this paper
• Free L-tryptophan plasma levels in antisocial violent offenders

  2001cites this paper
• Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease

  1998cites this paper
• Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease

  1998cites this paper
• Advances in the analysis of cerebrospinal fluid.

  1997cites this paper
• Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.

  1997cites this paper
• Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.

  1996cites this paper
• Cerebrospinal fluid nitrate levels in patients with Parkinson's disease

  1996cites this paper
• Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+

  1994cites this paper
• Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis.

  1994cites this paper
• Analysis of human cerebrospinal fluid by capillary electrophoresis with laser-induced fluorescence detection.

  1994cites this paper
• Capillary-zone electrophoretic analyses of the proteins and amino acid components in cerebrospinal fluid of central nervous system diseases.

  1993cites this paper
• Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease.

  1992cites this paper
• A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.

  1991cites this paper
• Levels ofpros-methylimidazoleacetic acid: Correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice

  1991cites this paper
• Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.

  1991cites this paper
• [Cerebrospinal fluid amino acids in Alzheimer's disease].

  1990cites this paper
• Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.

  1990cites this paper
• Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

  1990cites this paper
• Capillary-isotachophoretic determination of glutamine in cerebrospinal fluid of various neurological disorders.

  1989cites this paper
• In vivo influences on cerebrospinal fluid amino acid levels.

  1988cites this paper
• Determination of free amino acids in the cerebrospinal fluid of male rats by high-performance liquid chromatography with fluorescence detection. Alterations in amino acid concentrations during sexual activity.

  1987cites this paper
• Neurotransmitter glutamate: its clinical importance

  1986cites this paper
• Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration

  1986cites this paper
• Free and conjugated amino acids in human CSF: influence of age and sex.

  1985cites this paper
• Pathological Neurochemistry of Cerebrospinal Fluid

  1985cites this paper
• Triple-column ion-exchange physiological amino acid analysis with fluorescent detection: baseline characterization of human cerebrospinal fluid.

  1984cites this paper
• Elevated levels of amino acids in the CSF of motor neuron disease patients.

  1984cites this paper
• Zur Biosynthese von Aminosäuren aus Glukose im Zentralnervensystem beim Parkinsonsyndrom

  1983cites this paper
• [Biosynthesis of amino acids from glucose in the central nervous system in the Parkinson syndrome].

  1983cites this paper
• Studies on homocarnosine in cerebrospinal fluid in infancy and childhood. Part I. Homocarnosine level in cerebrospinal fluid of normal infants and children.

  1981cites this paper
• [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].

  1980cites this paper
• Neurochemical Alterations in Parkinson's Disease

  1980cites this paper
• Double-enzymatic assay for determination of glutamine and glutamic acid in cerebrospinal fluid and plasma.

  1978cites this paper
• Kinetics of uncatalyzed peroxydisulfate oxidation of organic material in fresh water

  1978cites this paper
• Free amino acid levels in amyotrophic lateral sclerosis

  1978cites this paper
• [Changes in the free amino acid spectrum in torsion dystonia patients].

  1977cites this paper
• Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders

  1976cites this paper
• HOMOCARNOSINOSIS. 2. A FAMILIAL METABOLIC DISORDER ASSOCIATED WITH SPASTIC PARAPLEGIA, PROGRESSIVE MENTAL DEFICIENCY, and RETINAL PIGMENTATION

  1976cites this paper
• Current publications in gerontology and geriatrics.

  1975cites this paper
• Recent articles in ageing research.

  1972cites this paper